NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer

European Surgical Research

Volumn 51, Issue 3-4, 2014, Pages 101-107

  Ogawa, R ^a   Ishiguro, H ^a   Kimura, M ^a   Funahashi, H ^a   Wakasugi, T ^a   Ando, T ^a   Shiozaki, M ^a   Takeyama, H ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Esophageal cancer; NOTCH1; Reverse transcription polymerase chain reaction

Indexed keywords

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, NOTCH1; RNA, MESSENGER;

NOTCH1 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84894487226     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000355674     Document Type: Article

References (24)

1. Isono K, Sato H, Nakayama K: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-420.
2. Pisani P, et al: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
3. Das I, et al: Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. J Biol Chem 2004; 279: 30771-30780.
4. Miele L: Notch signaling. Clin Cancer Res 2006; 12: 1074-1079.
5. Bray SJ: Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678-689.
6. Weng AP, et al: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271.
7. Miele L, Miao H, Nickoloff BJ: NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets 2006; 6: 313-323.
8. Wang Z, et al: Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 2006; 66: 2778-2784.
9. Wang Z, et al: Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006; 5: 483-493.
10. Artavanis-Tsakonas S, Matsuno K, Fortini ME: Notch signaling. Science 1995; 268: 225-232.
11. Ellisen LW, et al: TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649-661.
12. Weijzen S, et al: Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002; 8: 979-986.
13. Kitagawa Y, et al: Prognostic factors of esophageal cancer (in Japanese). Gan To Kagaku Ryoho 1998; 25: 2011-2020.
14. Itami A, et al: Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Oncology 1999; 57: 311-317.
15. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases. J Am Coll Surg 2001; 192: 708-718.
16. Hashimoto Y, et al: Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005; 11: 2597-2605.
17. Ren Y, et al: Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 2005; 11: 6190-6197.
18. Kato J, et al: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001; 95: 92-95.
19. Shibata Y, et al: Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol 2002; 32: 233-237.
20. Terashita Y, et al: Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 2002; 32: 238-243.
21. Konishi S, et al: Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer 2002; 95: 2473-2478.
22. Terashita Y, et al: Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer. Oncol Rep 2004; 12: 827-831.
23. Sugito N, et al: RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006; 12: 7322-7328.
24. Ogawa R, et al: Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009; 42: 102-109.